drugset / Trial / NCT00005054

Temozolomide in Treating Women With Advanced Breast Cancer

NCT00005054 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating women who have advanced breast cancer.

Timeline

Start
1998-05
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule — Oral

Indications